Laurus Labs' PAT jumps 313% yoy to Rs75cr in Q3FY20

Laurus Labs Ltd. announced its Q3 & 9M FY20 results on Thursday.

The company's PAT rose 313% yoy to Rs73.5cr in Q3FY20. Q3FY20 revenues grew 38% yoy to Rs729cr.

Q3FY20 EBITDA came in at Rs150cr up 68% Q3FY20 EBITDA margins at 21%

EPS (Diluted) for the period at Rs6.9cr (not annualized), rose 306% yoy.

Commenting on the results announcement, Dr. Satyanarayana Chava - CEO said, “Our Formulations business led by Low Middle Income Countries (LMIC) tenders has delivered significant growth in a very short time, resulting in a ~30% contribution to revenues on a 9M FY20 basis. With an enhanced focus on growth opportunities arising from LMIC markets, the contribution from the FDF business is expected to improve further. The growth in the developed markets will be driven by our product-specific approach.

Stock View:

Laurus Labs Ltd is currently trading at Rs440.20 up by Rs3.9 or 0.89% from its previous closing of Rs436.30 on the BSE.

The scrip opened at Rs460 and has touched a high and low of Rs460 and Rs435.60 respectively. So far 6,42,521 (NSE+BSE) shares were traded on the counter.

The current market cap of the company is Rs4,664.68cr.

About Gosip4U

Gosip4U is the digital wing of india - India's leading media and communications group with its interests spanning across country.


Post a Comment

Please add comment